Evaluation of Microbial Risk Factors in Relation to Clinical Effectiveness of Off-Label Bevacizumab Use for Retinal Disease Treatment: Research Article. Pak-Euro Journal of Medical and Life Sciences, [S. l.], v. 9, n. 1, p. 25–34, 2026. DOI: 10.31580/pjmls.v9i1.3417. Disponível em: https://readersinsight.net/index.php/PJMLS/article/view/3417. Acesso em: 2 may. 2026.